| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $286,720,707 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM147709 | Genomic signatures of primate-pathogen interactions | 000 | 2 | NIH | 8/2/2023 | $385,000 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99CA277580 | Identifying factors associated with ovarian cancer recurrence using a population-based approach | 001 | 1 | NIH | 2/28/2023 | $19,851 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS123162 | The dynamic balance between neuronal volume and chloride handling in network excitability after traumatic brain injury | 000 | 2 | NIH | 6/27/2023 | $385,000 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA275328 | Investigating molecular regulators of a mixed-lineage state in lung adenocarcinoma | 000 | 2 | NIH | 8/1/2023 | $37,806 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI168335 | Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings | 000 | 1 | NIH | 8/17/2023 | $704,133 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA284847 | SEMIColon: Somatic Exploration of Mosaicism in Colon | 000 | 1 | NIH | 8/11/2023 | $48,972 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HS029482 | Reducing Overuse of Antibiotics at Discharge: The ROAD Home Trial | 000 | 1 | AHRQ | 8/15/2023 | $500,000 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08HL168315 | The Role of Glycosyl Ceramides in Heart Failure and Recovery | 000 | 1 | NIH | 8/1/2023 | $179,280 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U54CA280812 | Multi-sector, multi-level interventions for improving cancer prevention and control addressing persistent poverty | 000 | 1 | NIH | 5/3/2023 | $1,968,971 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01HL169489 | A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility | 000 | 1 | NIH | 8/21/2023 | $133,966 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K12TR004413 | CTSA K12 Program at University of Utah: Early Career Faculty Development Program | 001 | 1 | NIH | 7/26/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM146671 | A bioanalytical research program to unravel the human milk glycome | 000 | 2 | NIH | 8/21/2023 | $371,336 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25GM144253 | Intermountain PREP | 000 | 2 | NIH | 8/1/2023 | $311,185 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL163145 | Endovascular blood pressure targeting in cardiac arrest, a translational research study | 000 | 2 | NIH | 7/25/2023 | $557,546 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY033365 | The Impact of Non-Exudative Type 1 Macular Neovascularization (MNV) on Age-related Macular Degeneration (AMD) Progression | 000 | 2 | NIH | 6/22/2023 | $385,000 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG080530 | Dyadic Sleep, Biobehavioral Rhythms and Cognitive Function in Older Adults: Implications for Alzheimer?s Disease | 000 | 1 | NIH | 3/23/2023 | $990,466 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD107077 | Economic security policy and birth outcomes among socio-economically disadvantaged women | 000 | 1 | NIH | 4/10/2023 | $345,246 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS128630 | Investigation on Ataxin2 and Matrin3 in neurodegenerative disease | 000 | 1 | NIH | 3/31/2023 | $422,125 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R38HL167282 | Utah Stimulating Access to Research in Residency | 000 | 1 | NIH | 1/18/2023 | $231,044 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 001 | 1 | NIH | 2/23/2023 | -$366 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR081006 | Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial | 000 | 1 | NIH | 12/1/2022 | $169,079 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG080502 | A new biomarker for frontotemporal lobar degeneration with TDP-43 proteinopathy and Alzheimer's disease | 001 | 1 | NIH | 3/21/2023 | $130 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K22CA258671 | Opioid-induced changes to chemotherapeutic activity in blood cancer | 000 | 2 | NIH | 7/28/2023 | $201,457 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01CK000675 | RFA-CK-22-008, TRANSMIT: Training Research Acumen in Students Modeling Infectious Threats | 00 | 2 | CDC | 8/23/2023 | $120,415 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA275266 | Epigenetic regulation of NKX2-1-negative lung adenocarcinoma cellular identity by FoxA1 and FoxA2 | 000 | 2 | NIH | 8/1/2023 | $47,694 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082952 | Morphologic and Kinematic Adaptations of the Subtalar Joint after Ankle Fusion Surgery in Patients with Varus-type Ankle Osteoarthritis | 000 | 1 | NIH | 9/12/2023 | $551,269 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U54HD113169 | ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah | 001 | 1 | NIH | 8/17/2023 | $1,949,666 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R56AI174930 | Regulation and Manipulation of Innate Immunity During HIV Infection | 000 | 1 | NIH | 8/15/2023 | $668,416 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA281759 | Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial | 000 | 1 | NIH | 8/24/2023 | $692,568 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HD112548 | P-KIDs CARE: An Intervention to Address Health Systems Delays to Care for Injured Children in Tanzania | 000 | 1 | NIH | 8/24/2023 | $174,960 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DA058621 | Optimizing Patient-Centered Opioid Tapering with Mindfulness-Oriented Recovery Enhancement | 000 | 1 | NIH | 8/4/2023 | $3,414,522 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K12TR004413 | CTSA K12 Program at University of Utah: Early Career Faculty Development Program | 000 | 1 | NIH | 4/17/2023 | $971,200 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AA030881 | Transcriptional Regulation of Alcohol Sensitivity and Tolerance | 000 | 1 | NIH | 5/5/2023 | $520,981 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NUR3DD000102 | The Utah Registry of Autism and Developmental Disabilities: Enhancing Public Health Surveillance of Autism Spectrum Disorder in Utah through the Autism and Developmental Disabilities Monitoring (ADDM) | 01 | 1 | CDC | 8/9/2023 | $276,963 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG3NS132134 | A reference-free computational algorithm for comprehensive somatic mosaic mutation detection | 000 | 1 | NIH | 3/28/2023 | $384,588 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 000 | 1 | NIH | 4/7/2023 | $144,259 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 000 | 1 | NIH | 1/19/2023 | $539,930 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG080502 | A new biomarker for frontotemporal lobar degeneration with TDP-43 proteinopathy and Alzheimer's disease | 000 | 1 | NIH | 12/29/2022 | $260,176 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | US647233 | Nurse Education Practice Quality and Retention- Registered Nurse Training Program | 01 | 2 | HRSA | 8/24/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 S. Presidents Circle, Rm. 408 Park Building | Salt Lake City | UT | 84112-9023 | SALT LAKE | USA | US647233 | Nurse Education Practice Quality and Retention- Registered Nurse Training Program | 00 | 2 | HRSA | 7/13/2023 | $312,726 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31DK130542 | Investigation of Drug-Drug and Drug-Circuit Interactions in Children on Continuous Renal Replacement Therapy | 000 | 2 | NIH | 5/23/2023 | $38,726 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI170942 | A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease. | 000 | 2 | NIH | 6/15/2023 | $734,968 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31NR020431 | Examining associations between social network characteristics, obesity-related health behaviors, and weight retention among racially/ethnically diverse postpartum women | 000 | 2 | NIH | 6/30/2023 | $39,978 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA276653 | Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology | 000 | 1 | NIH | 9/12/2023 | $390,494 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U54HD113169 | ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah | 001 | 1 | NIH | 8/17/2023 | -$1,949,666 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R56AI150474 | Architecture and dynamics of immature HIV lattice | 000 | 6 | NIH | 8/14/2023 | $452,280 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08HL165084 | Towards Precision Medicine for Thoracic Aortic Disease: Defining the Clinical and Genomic Drivers of Bicuspid Aortopathy | 000 | 1 | NIH | 4/24/2023 | $171,213 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08HG013111 | Addressing the research-practice gap in the implementation of rapid whole genome sequencing in the NICU | 000 | 1 | NIH | 9/1/2023 | $269,246 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K24AI166087 | Mentoring patient-oriented researchers in pediatric diarrhea | 000 | 1 | NIH | 5/11/2023 | $171,918 |
|
